Wegovy is an FDA-approved medication for weight management, taken once a week
Develop Monitoring Schedules for Tracking Efficacy and Side Effects Create standardized assessment protocols: Implement consistent metrics for tracking weight, HbA1c, blood pressure, lipids, and other relevant biomarkers
The short answer: Yes, but usually mild and rare when taken at recommended doses
Kickstart fat loss & regulate blood sugar
Compared to GLP-1 Agonists: Weight management peptides like semaglutide and tirzepatide have demonstrated weight loss efficacy superior to AOD-9604 in clinical trials, but they also have distinct side effect profiles
Polycystic ovary syndrome (PCOS) which was recently renamed polyendocrine metabolic ovarian syndrome (PMOS) affects up to 5 million women in the U.S., yet diagnoses are often missed or delayed, and managing the condition remains inconsistent